Skip to main content
Lakshminarayanan Nandagopal, MD, Oncology, Birmingham, AL, University of Alabama Hospital

LakshminarayananNandagopalMD

Oncology Birmingham, AL

Physician

Dr. Nandagopal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nandagopal's full profile

Already have an account?

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
  • University of Alabama at Birmingham
    University of Alabama at BirminghamCertificate, Clinical and Translational Science, 2017
  • University of Alabama at Birmingham
    University of Alabama at BirminghamCertificate, Clinical Investigator Training Program, 2017
  • Wayne State University School of Medicine
    Wayne State University School of MedicineResidency, Internal Medicine, 2010 - 2013
  • Other
    OtherClass of 2008

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2022 - 2024
  • AL State Medical License
    AL State Medical License 2015 - 2022
  • MI State Medical License
    MI State Medical License 2010 - 2016
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma  
    Nandagopal L, Naik G, Sonpavde G, Current treatment options in Oncology, 1/18/2018
  • Timing of androgen deprivation therapy in prostate cancer  
    Nandagopal L, Lancet Oncology, 1/1/2017
  • Treatment approaches of hard-to-treat non-Hodgkin lymphomas  
    Nandagopal L, Mehta AK, Expert Review of Hematology, 1/1/2016
  • Join now to see all

Abstracts/Posters

  • Improving hepatitis B screening prior to Rituximab-based treatments at a multi-specialty urban VA hospital
    Nandagopal L, Paluri R, Gleaton B, Nabell L, ASCO Quality Care Symposium, Orlando, FL, 1/1/2017
  • Factors affecting outcomes in gall bladder cancer � a single institution retrospective analysis
    Nandagopal L, Heslin M, Porterfield J R, Javob R, Li P, Posey J, Paluri R, AACR annual meeting, 1/1/2017
  • The diagnostic and therapeutic challenges in an unusual case of Stills disease and Systemic lupus erythematosus overlap - A Spectrum of Auto-inflammatory Syndrome?
    Nandagopal L, Itikyala S, Neill D, Nagori K,Ramchandren R, Krishnamurthy V, Sagar H, York R, Venkatram M, ACP Associates Day, MI, 1/1/2014
  • Join now to see all

Lectures

  • Urothelial carcinoma 
    University of Alabama at Birmingham, Birmingham, AL - 1/1/2018
  • Molecular advances in prostate cancer 
    University of Alabama at Birmingham, Birmingham, AL - 1/1/2018
  • Prostate cancer 101- a primer for Fellows 
    1/1/2018
  • Join now to see all

Hospital Affiliations